Title
Category
Credits
Event date
Cost
- CMHC
- 19.25 ACPE Pharmacy
- 19.25 AMA PRA Category 1 Credit™
- 19.25 ANCC
- 19.25 CDE
- 19.25 Participation
$0.00
The recordings from the 18th Annual meeting are now available.
- CMHC
- 0.75 ACPE Pharmacy
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
- 0.75 Participation
$0.00
This clinical brief was developed from a presentation at the 2023 Women's Health and Wellness Masterclass held August 2023 in Dana Point, CA. The session, “Resistant Hypertension in Women: Dispelling Common Myths and Recent Clinical Advances,” was presented by Keith C. Ferdinand, MD, supported by an educational grant from Medtronic.
- LivDerm
- TME
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
- 0.75 Participation
$0.00
Traditional treatments for seborrheic dermatitis, including oral and topical steroids, present a variety of challenges including lack of efficacy, adverse events with long-term use, limitations for adherence, and the inability to treat both hair- and non-hair-bearing areas. Recently, the first targeted therapy for treatment of seborrheic dermatitis, a PDE-4 inhibitor topical foam, was approved by the FDA.